Skip to main content

Supportive Care in Cancer

Ausgabe 12/2017

Inhalt (23 Artikel)

Commentary

Evidence of depression-associated circadian rhythm disruption and regret in prostate cancer patients after surgery

Joanne Christie, Christopher F Sharpley, Vicki Bitsika, David Christie

Review Article

Risk factors of pain in breast cancer survivors: a systematic review and meta-analysis

Laurence Leysen, David Beckwée, Jo Nijs, Roselien Pas, Thomas Bilterys, Sofie Vermeir, Nele Adriaenssens

Original Article

The effects of oncology massage on symptom self-report for cancer patients and their caregivers

Gabriel Lopez, Wenli Liu, Kathrin Milbury, Amy Spelman, Qi Wei, Eduardo Bruera, Lorenzo Cohen

Open Access Original Article

Optimizing VAP scars after childhood cancer treatment: a pilot study

C. M. A. de Bruijn, F. W. Hoff, M. M. Bruggeman-Westermann, J. B. Terra, T. H. van Dijk, E. S. J. M. de Bont, A. M. L. Peek

Original Article

Resistance training as supportive measure in advanced cancer patients undergoing TKI therapy—a controlled feasibility trial

F. Rosenberger, J. Wiskemann, S. Vallet, G. M. Haag, E. Schembri, D. Jäger, C. Grüllich

Original Article

First Descents, an adventure program for young adults with cancer: who benefits?

Brad Zebrack, Minyoung Kwak, Laura Sundstrom

Open Access Original Article

Feasibility of a self-help web-based intervention targeting young cancer patients with sexual problems and fertility distress

Maria Wiklander, Johanna Strandquist, Claire Micaux Obol, Lars E. Eriksson, Jeanette Winterling, Kenny A. Rodriguez-Wallberg, Kerstin Sjögren Fugl-Meyer, Johan Ahlgren, Per Ljungman, Claudia Lampic, Lena Wettergren

Original Article

From will to live to will to die: oncologists, nurses, and social workers identification of suicidality in cancer patients

Leeat Granek, Ora Nakash, Samuel Ariad, Wendy Chen, Shira Birenstock-Cohen, Shahar Shapira, Merav Ben-David

Original Article

Care burden and its predictive factors in parents of newly diagnosed children with acute lymphoblastic leukemia in academic hospitals in China

Jingting Wang, Nanping Shen, Xiaoyan Zhang, Min Shen, Anwei Xie, Doris Howell, Changrong Yuan

Original Article

Provider perspectives on barriers and facilitators to adjuvant endocrine therapy-related symptom management

Cleo A. Samuel, Kea Turner, Heidi A. S. Donovan, Ellen Beckjord, Alexandra Cardy, Mary Amanda Dew, G. J. van Londen

Original Article

Effectiveness of intervention with a perioperative multidisciplinary support team for radical esophagectomy

Yuji Akiyama, Takeshi Iwaya, Fumitaka Endo, Yoshihiro Shioi, Motoi Kumagai, Takeshi Takahara, Koki Otsuka, Hiroyuki Nitta, Keisuke Koeda, Masaru Mizuno, Yusuke Kimura, Kenji Suzuki, Akira Sasaki

Original Article

Sleep quality in long-term survivors of head and neck cancer: preliminary findings

Na Li, Takafumi Otomaru, Hisashi Taniguchi

Original Article

Caregiver perspectives on the social competence of pediatric brain tumor survivors

Matthew C. Hocking, Lauren F. Quast, Cole Brodsky, Janet A. Deatrick

Open Access Original Article

Multicenter, cross-sectional observational study of the impact of neuropathic pain on quality of life in cancer patients

So Yeon Oh, Sang Won Shin, Su-Jin Koh, Sang Byung Bae, Hyun Chang, Jung Han Kim, Hyo Jung Kim, Young Seon Hong, Keon Uk Park, Jeanno Park, Kyung Hee Lee, Na Ri Lee, Jung Lim Lee, Joung Soon Jang, Dae Sik Hong, Seung-Sei Lee, Sun Kyung Baek, Dae Ro Choi, Jooseop Chung, Sang Cheul Oh, Hye Sook Han, Hwan Jung Yun, Sun Jin Sym, So Young Yoon, In Sil Choi, Byoung Yong Shim, Seok Yun Kang, Sung Rok Kim, Hyun Joo Kim

Original Article

A cross sectional review of patient information available in the World Wide Web on CyberKnife: fallacies and pitfalls

Durgapoorna Menon, Prameela G. Chelakkot, Devika Sunil, Ashwini Lakshmaiah

Open Access Original Article

Durable usage of patient-reported outcome measures in clinical practice to monitor health-related quality of life in head and neck cancer patients

S. Duman-Lubberding, C. F. van Uden-Kraan, F. Jansen, B. I. Witte, S. E. J. Eerenstein, S. van Weert, R. de Bree, C. R. Leemans, I. M. Verdonck-de Leeuw

Original Article

Symptom self-management strategies reported by adolescents and young adults with cancer receiving chemotherapy

Lauri A. Linder, Jeanne M. Erickson, Kristin Stegenga, Catherine Fiona Macpherson, Sarah Wawrzynski, Christina Wilson, Suzanne Ameringer

Original Article

Acupuncture for cancer-related fatigue in lung cancer patients: a randomized, double blind, placebo-controlled pilot trial

Chien-shan Cheng, Lian-yu Chen, Zhou-yu Ning, Chen-yue Zhang, Hao Chen, Zhen Chen, Xiao-yan Zhu, Jing Xie

Original Article

Vaccination against influenza at a European pediatric cancer center: immunization rates and attitudes among staff, patients, and their families

Aleksandra Pettke, Sophie Jocham, Andreas Wiener, Andreas Löcken, Judith Groenefeld, Martina Ahlmann, Andreas H. Groll

Original Article

Lifestyle advice provision to teenage and young adult cancer patients: the perspective of health professionals in the UK

Gemma Pugh, Rachael Hough, Helen Gravestock, Kate Williams, Abigail Fisher

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.